Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization
This is the company's second FDA clearance, broadening its suite of fully digital platforms to cater to all lab sizes and networks
TEL AVIV, Israel, June 9, 2022 -- (Healthcare Sales & Marketing Network) -- Scopio Labs, a medtech company that develops ... Devices, Diagnostics, FDA Scopio Labs, X100HT, Peripheral Blood Smear
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Hematology | Information Technology | Israel Health | Marketing | Middle East Health | Papanicolaou (Pap) Smear | Pharmaceuticals